Cargando…
Human TRIM5α: Autophagy Connects Cell-Intrinsic HIV-1 Restriction and Innate Immune Sensor Functioning
Human immunodeficiency virus-1 (HIV-1) persists as a global health concern, with an incidence rate of approximately 2 million, and estimated global prevalence of over 35 million. Combination antiretroviral treatment is highly effective, but HIV-1 patients that have been treated still suffer from chr...
Autores principales: | Cloherty, Alexandra P. M., Rader, Anusca G., Compeer, Brandon, Ribeiro, Carla M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923229/ https://www.ncbi.nlm.nih.gov/pubmed/33669846 http://dx.doi.org/10.3390/v13020320 |
Ejemplares similares
-
Autophagy-enhancing drugs limit mucosal HIV-1 acquisition and suppress viral replication ex vivo
por: Cloherty, Alexandra P. M., et al.
Publicado: (2021) -
Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade
por: Cloherty, Alexandra P. M., et al.
Publicado: (2023) -
Role of Human TRIM5α in Intrinsic Immunity
por: Nakayama, Emi E., et al.
Publicado: (2012) -
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
por: Pertel, Thomas, et al.
Publicado: (2011) -
TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity
por: Kimura, Tomonori, et al.
Publicado: (2015)